- Home
- DAWN vs ASPI Comparison
DAWN vs ASPI Comparison
Compare DAWN & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- ASPI
- Stock Information
- Founded
- DAWN 2018
- ASPI 2021
- Country
- DAWN United States
- ASPI United States
- Employees
- DAWN N/A
- ASPI N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- ASPI Major Chemicals
- Sector
- DAWN Health Care
- ASPI Industrials
- Exchange
- DAWN Nasdaq
- ASPI Nasdaq
- Market Cap
- DAWN 658.9M
- ASPI 653.4M
- IPO Year
- DAWN 2021
- ASPI 2022
- Fundamental
- Price
- DAWN $6.71
- ASPI $9.07
- Analyst Decision
- DAWN Strong Buy
- ASPI Strong Buy
- Analyst Count
- DAWN 6
- ASPI 2
- Target Price
- DAWN $30.17
- ASPI $7.75
- AVG Volume (30 Days)
- DAWN 1.3M
- ASPI 4.9M
- Earning Date
- DAWN 08-05-2025
- ASPI 08-18-2025
- Dividend Yield
- DAWN N/A
- ASPI N/A
- EPS Growth
- DAWN N/A
- ASPI N/A
- EPS
- DAWN N/A
- ASPI N/A
- Revenue
- DAWN $161,922,000.00
- ASPI $4,405,477.00
- Revenue This Year
- DAWN $17.98
- ASPI $512.64
- Revenue Next Year
- DAWN $49.50
- ASPI $181.15
- P/E Ratio
- DAWN N/A
- ASPI N/A
- Revenue Growth
- DAWN N/A
- ASPI 245.97
- 52 Week Low
- DAWN $6.08
- ASPI $1.86
- 52 Week High
- DAWN $16.76
- ASPI $10.82
- Technical
- Relative Strength Index (RSI)
- DAWN 47.98
- ASPI 52.80
- Support Level
- DAWN $6.32
- ASPI $9.33
- Resistance Level
- DAWN $7.18
- ASPI $10.82
- Average True Range (ATR)
- DAWN 0.29
- ASPI 0.93
- MACD
- DAWN 0.01
- ASPI -0.00
- Stochastic Oscillator
- DAWN 36.11
- ASPI 50.70
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.